Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph P Insinga

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|October 24, 2006
Annual productivity costs due to cervical cancer mortality in the United StatesRalph P Insinga
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 2003
Understanding differences between self-ratings and population ratings for health in the EuroQOLRalph P Insinga, Dennis G Fryback
Pharmacoeconomics|October 15, 2008
A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluationHirsch S Ruchlin, Ralph P Insinga
Emerging Infectious Diseases|March 21, 2007
Model for assessing human papillomavirus vaccination strategiesElamin H Elbasha, Erik J Dasbach, Ralph P Insinga
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
The health and economic burden of genital warts in a set of private health plans in the United StatesRalph P Insinga, Erik J Dasbach, Evan R Myers
American Journal of Obstetrics and Gynecology|August 6, 2004
Diagnoses and outcomes in cervical cancer screening: a population-based studyRalph P Insinga, Andrew G Glass, Brenda B Rush
Pharmacoeconomics|January 26, 2007
Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plansRalph P Insinga, Robbin F Itzler, James M Pellissier
Epidemiologic Reviews|June 3, 2006
Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and diseaseErik J Dasbach, Elamin H Elbasha, Ralph P Insinga
Pharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Health Policy (Amsterdam, Netherlands)|November 22, 2005
Response to "Use of cervical cancer screening among insured women: the extent of missed opportunities" [Health Policy 73 (2005) 194-201]Ralph P Insinga, Andrew G Glass, Brenda B Rush
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|October 24, 2006
Annual productivity costs due to cervical cancer mortality in the United StatesRalph P Insinga
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 2003
Understanding differences between self-ratings and population ratings for health in the EuroQOLRalph P Insinga, Dennis G Fryback
Pharmacoeconomics|October 15, 2008
A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluationHirsch S Ruchlin, Ralph P Insinga
Emerging Infectious Diseases|March 21, 2007
Model for assessing human papillomavirus vaccination strategiesElamin H Elbasha, Erik J Dasbach, Ralph P Insinga
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
The health and economic burden of genital warts in a set of private health plans in the United StatesRalph P Insinga, Erik J Dasbach, Evan R Myers
American Journal of Obstetrics and Gynecology|August 6, 2004
Diagnoses and outcomes in cervical cancer screening: a population-based studyRalph P Insinga, Andrew G Glass, Brenda B Rush
Pharmacoeconomics|January 26, 2007
Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plansRalph P Insinga, Robbin F Itzler, James M Pellissier
Epidemiologic Reviews|June 3, 2006
Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and diseaseErik J Dasbach, Elamin H Elbasha, Ralph P Insinga
Pharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Health Policy (Amsterdam, Netherlands)|November 22, 2005
Response to "Use of cervical cancer screening among insured women: the extent of missed opportunities" [Health Policy 73 (2005) 194-201]Ralph P Insinga, Andrew G Glass, Brenda B Rush
Pageof 5